CN1066602A - The compound method of hypoglycemic compound capsule - Google Patents
The compound method of hypoglycemic compound capsule Download PDFInfo
- Publication number
- CN1066602A CN1066602A CN 92106161 CN92106161A CN1066602A CN 1066602 A CN1066602 A CN 1066602A CN 92106161 CN92106161 CN 92106161 CN 92106161 A CN92106161 A CN 92106161A CN 1066602 A CN1066602 A CN 1066602A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- vitamin
- powder
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the compounding process of medicine.It is with the Radix Ginseng Rubra in the prescription, Poria, Rhizoma Dioscoreae, pollen, Radix Puerariae, Rhizoma Atractylodis Macrocephalae clean dry and pulverized 120 mesh sieves, gets smalls shape material 1; The Radix Rehmanniae, Rhizoma Alismatis, Rhizoma Coptidis, Cortex Phellodendri, Fructus Schisandrae Chinensis, Fructus Lycii, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Dioscoreae, Rhizoma Atractylodis are cleaned the back decocting and were boiled 1-2 hour, get that its filtrate is concentrated into paste and drying and crushing is crossed 120 mesh sieves, smalls shape material 2; Get vitamin c powder and vitamin B
1Powder mixes with material 1, material 2 to be mixed thoroughly, divides the capsule of packing into by every weight 0.3 gram.The capsule of being made is respond well to diabetic therapy, has no side effect, and patient's medication is convenient, and preparation method is simple.
Description
The invention belongs to the compounding process of medicine.
For treatment of diabetes, normally adopt insulin injection and oral sulfonylurea and biguanides oral medicine.It is D860 and glyburide etc. that sulfonylurea is mainly represented medicine, and these medicines clinically can only be effective to the mild or moderate diabetics that pancreatic function does not completely lose, and are very poor to juvenile form and severe diabetics curative effect; If taking dose is careless slightly, can cause allergic reaction, erythra, thrombocytopenia or hypoplastic anemia appear, the patient who has also gastrointestinal reaction can occur, as nauseating, vomiting, inappetence, organs such as Liver and kidney also directly there is detrimental effect, so the bad diabetics of hepatic and renal function is definitely prohibited clothes.If dosage has slightly and excessively also hypoglycemic reaction can occur, visible clinically dizzy margins of eyelids, hands are trembled hyperhidrosis, babble, faint etc.Another kind of oral medicine is a biguanides, and insoral is this type of medicine, and it also has tangible gastrointestinal irritation, as nausea,vomiting,diarrhea etc.Have the disease patient all to prohibit this medicine of clothes as liver, kidney, cardiovascular, the medication treatment that this has just greatly limited diabetics also can cause lactic acidosis if use by force, can cause death as can not in time rescuing also.If the improper hypoglycemic reaction that causes of insuline pro injection consumption, and stupor, cardiopalmus, fidgety, hyperhidrosis appear, hands is trembled diseases such as unable, severe patient also can cause faint from fear dead.Insulin still can cause allergic reaction and local irritant reaction except that can causing the side effect that oral drugs cause, and red and swollen scleroma etc. can appear in the subcutaneous injection part.Make insulinize, the patient also has intensive anaclisis, in case use, is difficult to lose.No matter use which kind of Western medicine all easily to cause microangiopathies.Insulin injection treatment, its effective percentage is also non-very definite, a lot of patient's medications are arranged after the state of an illness still, only keep.
The present invention is directed to the shortcoming of above-mentioned existence, provide a kind of therapeutic effect good, be easy to take, and without any side effects, and the compound method that can prevent the Jiangtang capsule of multiple complications.
Main points of the present invention are:
With the Radix Ginseng Rubra in the prescription, Poria, Rhizoma Dioscoreae, pollen, Radix Puerariae, Rhizoma Atractylodis Macrocephalae clean dry and pulverized 120 mesh sieves, smalls shape material 1; The Radix Rehmanniae, Herba Euphorbiae Helioscopiae, Rhizoma Coptidis, Cortex Phellodendri, Fructus Schisandrae Chinensis, Fructus Lycii, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Dioscoreae, Rhizoma Atractylodis are cleaned the back decocting and were boiled 1-2 hour, get that its filtrate is concentrated into paste and drying and crushing is crossed 120 mesh sieves, smalls shape material 2; Get vitamin c powder and vitamin B
1Powder mixes with material 1, material 2 to be mixed thoroughly, divides the capsule of packing into by every weight 0.3 gram.
The consumption of respectively distinguishing the flavor of during preparation in the prescription is by weight:
Radix Ginseng Rubra 3-7 part, Poria 1-5 part, Radix Rehmanniae 4-7 part, Rhizoma Anemarrhenae 3-5 part, Radix Astragali 3-5 part, Radix Puerariae 4-7 part, pollen 3-5 part, Herba Euphorbiae Helioscopiae 4-7 part, Rhizoma Coptidis 1-4 part, Rhizoma Dioscoreae 3-7 part, Rhizoma Dioscoreae 4-7 part, Fructus Lycii 4-7 part, Fructus Schisandrae Chinensis 3-7 part, Cortex Phellodendri 2-5 part, Rhizoma Atractylodis Macrocephalae 4-6 part, Rhizoma Atractylodis 1-3 part; Vitamin c powder 2-5 part, vitamin B
1Powder 2-4 part.
The made capsule of the present invention is respond well to diabetic therapy, do not have side effect oral before and that the insulin injection pharmacotherapy is brought, and patient's medication is convenient, and its preparation method is simple.It is for type patient's treatment, curative effect is definite rapidly, take without any side effects for a long time, particularly the bad diabeticss of function such as those livers, heart, kidney can be taken for a long time, have solved liver, the heart, the bad diabetics of renal function and can not take the drawbacks that medicine brought such as glyburide.The decapacitation of this medicine is eliminated outside the clinical symptoms, and also blood sugar lowering, glucose in urine, recovery body function rapidly provide new oral therapeutic drug for treating type.
Embodiment:
Get Radix Ginseng Rubra (going to join reed) 3500 gram, Poria 2000 grams, Rhizoma Dioscoreae 1500 grams, pollen 1500 grams, Radix Puerariae 2000 grams, the Rhizoma Atractylodis Macrocephalae 2500 grams, clean and crushed after being dried is crossed 120 mesh sieves and must be expected that 1 is stand-by; The Radix Rehmanniae 3000 grams, Herba Euphorbiae Helioscopiae 2500 grams, Rhizoma Coptidis 2000 grams, Cortex Phellodendri 1500 grams, Fructus Schisandrae Chinensis 2000 grams, Fructus Lycii 2500 grams, the Rhizoma Anemarrhenae 1500 grams, the Radix Astragali 1500 grams, Rhizoma Dioscoreae 2000 grams, Rhizoma Atractylodis 2000 grams are cleaned the back decocting and boiled 1.5 hours, get its filtrate then and be concentrated into paste, it is smalls shape material 2 that drying was pulverized 120 mesh sieves; Material 1 merges with material 2 and adds vitamin c powder 1500 grams, vitamin B again
1Powder 1000 gram, abundant mixing and stirring, sterilization again divides encapsulatedly, and every contains powder medicine 0.3 gram, and the sterilization tinfoil paper of packing into gets finished product.
This made Jiangtang capsule is a combination of Chinese and Western medicine medicine, see from integral body have strengthening vital QI to eliminate pathogenic factors, the effect of supplementing QI and nourishing YIN, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, enhancing human body immunity function and hepatocyte activity.Its prescription is reasonable, the curative effect height, and the medicine source is abundant, and easy to utilize, total effective rate can reach more than 92%, and clinical cure rate is more than 43%.
Claims (1)
1, a kind of compound method of hypoglycemic compound capsule is characterized in that:
A, Radix Ginseng Rubra, Poria, Rhizoma Dioscoreae, pollen, Radix Puerariae, Rhizoma Atractylodis Macrocephalae clean dry with in the prescription and pulverized 120 mesh sieves, smalls shape material 1; The Radix Rehmanniae, Herba Euphorbiae Helioscopiae, Rhizoma Coptidis, Cortex Phellodendri, Fructus Schisandrae Chinensis, Fructus Lycii, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Dioscoreae, Rhizoma Atractylodis are cleaned the back decocting and were boiled 1-2 hour, get that its filtrate is concentrated into paste and drying and crushing is crossed 120 mesh sieves, smalls shape material 2; Get vitamin c powder and vitamin B
1Powder mixes with material 1, material 2 to be mixed thoroughly, divides the capsule of packing into by every weight 0.3 gram;
The consumption of respectively distinguishing the flavor of when b, preparation in the prescription is by weight:
Radix Ginseng Rubra 3-7 part, Poria 1-5 part, Radix Rehmanniae 4-7 part, Rhizoma Anemarrhenae 3-5 part, Radix Astragali 3-5 part, Radix Puerariae 4-7 part, pollen 3-5 part, Herba Euphorbiae Helioscopiae 4-7 part, Rhizoma Coptidis 1-4 part, Rhizoma Dioscoreae 3-7 part, Rhizoma Dioscoreae 4-7 part, Fructus Lycii 4-7 part, Fructus Schisandrae Chinensis 3-7 part, Cortex Phellodendri 2-5 part, Rhizoma Atractylodis Macrocephalae 4-6 part, Rhizoma Atractylodis 1-3 part; Vitamin c powder 2-5 part, vitamin B
1Powder 2-4 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 92106161 CN1046633C (en) | 1992-05-08 | 1992-05-08 | Compound melbine capsule and making process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 92106161 CN1046633C (en) | 1992-05-08 | 1992-05-08 | Compound melbine capsule and making process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1066602A true CN1066602A (en) | 1992-12-02 |
CN1046633C CN1046633C (en) | 1999-11-24 |
Family
ID=4941855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 92106161 Expired - Fee Related CN1046633C (en) | 1992-05-08 | 1992-05-08 | Compound melbine capsule and making process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1046633C (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056980C (en) * | 1994-11-08 | 2000-10-04 | 谢春生 | Compound balsom pear capsules for curing diabetes and prepn. method thereof |
CN1066332C (en) * | 1994-02-04 | 2001-05-30 | 河北省沧州中药厂 | Hypoglycemic compound capsule |
CN1071120C (en) * | 1996-03-06 | 2001-09-19 | 宫君平 | Shihua drink made from traditional Chinese medicine |
CN1087627C (en) * | 1999-12-15 | 2002-07-17 | 邵玉君 | Medicament for treating diabetes and its preparation method |
CN1116052C (en) * | 2000-07-13 | 2003-07-30 | 郭连川 | 'Yidaosheng' capsules |
CN101982194A (en) * | 2010-11-17 | 2011-03-02 | 西南大学 | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
CN102988757A (en) * | 2012-12-18 | 2013-03-27 | 兰州派奥尼生物科技有限公司 | Traditional Chinese medicine preparation used for treating diabetes mellitus |
CN104606487A (en) * | 2015-01-20 | 2015-05-13 | 李兴尧 | Fermented traditional Chinese medicine preparation as well as preparation method and application thereof |
CN105283795A (en) * | 2013-06-28 | 2016-01-27 | 爱信艾达株式会社 | Head-up display device |
-
1992
- 1992-05-08 CN CN 92106161 patent/CN1046633C/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1066332C (en) * | 1994-02-04 | 2001-05-30 | 河北省沧州中药厂 | Hypoglycemic compound capsule |
CN1056980C (en) * | 1994-11-08 | 2000-10-04 | 谢春生 | Compound balsom pear capsules for curing diabetes and prepn. method thereof |
CN1071120C (en) * | 1996-03-06 | 2001-09-19 | 宫君平 | Shihua drink made from traditional Chinese medicine |
CN1087627C (en) * | 1999-12-15 | 2002-07-17 | 邵玉君 | Medicament for treating diabetes and its preparation method |
CN1116052C (en) * | 2000-07-13 | 2003-07-30 | 郭连川 | 'Yidaosheng' capsules |
CN101982194A (en) * | 2010-11-17 | 2011-03-02 | 西南大学 | Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes |
CN102988757A (en) * | 2012-12-18 | 2013-03-27 | 兰州派奥尼生物科技有限公司 | Traditional Chinese medicine preparation used for treating diabetes mellitus |
CN105283795A (en) * | 2013-06-28 | 2016-01-27 | 爱信艾达株式会社 | Head-up display device |
CN104606487A (en) * | 2015-01-20 | 2015-05-13 | 李兴尧 | Fermented traditional Chinese medicine preparation as well as preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1046633C (en) | 1999-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103083531B (en) | Drug for treating diabetes | |
CN104666768A (en) | Traditional Chinese medicine health preparation for nourishing qi and blood | |
CN101352539A (en) | Composite of Chinese traditional medicine for diabetes mellitus | |
CN1046633C (en) | Compound melbine capsule and making process | |
CN1027622C (en) | Tonic medicine | |
CN1069203C (en) | Drug for curing diabetes | |
CN102423435B (en) | Chinese medicine for treating infantile malnutrition and preparation method thereof | |
CN103341089B (en) | Traditional Chinese medicine preparation for treating infantile anorexia | |
CN102188612A (en) | Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof | |
CN1305816A (en) | Medicine for treating diabetes | |
CN1242775C (en) | Bushenshansong drink and preparation method thereof | |
CN103599343A (en) | Pharmaceutical composition for treating diabetes, and preparation method and application thereof | |
CN1022165C (en) | Preparation and process of oral medicinal liquid for recuperating blood vessels | |
CN1315186A (en) | Medical tea for treating leukoderma and its preparing process | |
CN1422628A (en) | Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia | |
CN1051931C (en) | Compound preparation for curing nutritional iron-deficiency anemia | |
CN1132095A (en) | Nurishing tonic for building body | |
CN1066063C (en) | Chinese medicine preparation for treating infantile diarrhea | |
CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
CN101637565A (en) | Pure Chinese medicinal preparation for treating arrhythmia | |
CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
CN114259540B (en) | Traditional Chinese medicine composition for treating diabetes with syndrome of deficiency of both qi and yin and preparation method and application thereof | |
CN1114568A (en) | Antidiarrheal powder for baby | |
CN1306830A (en) | Medicine for treating Type-11 diabetes | |
CN1330338C (en) | Medicine for reinforcing primordial qi of late stage cancer patents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |